News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
377,143 Results
Type
Article (25758)
Company Profile (61)
Press Release (351324)
Section
Business (104209)
Career Advice (448)
Deals (16873)
Drug Delivery (47)
Drug Development (47544)
Employer Resources (47)
FDA (12234)
Job Trends (8424)
News (185800)
Policy (19394)
Tag
Academia (1730)
Alliances (26652)
Alzheimer's disease (755)
Approvals (12245)
Artificial intelligence (117)
Bankruptcy (137)
Best Places to Work (6881)
Breast cancer (145)
Cancer (1004)
Cardiovascular disease (86)
Career advice (407)
Cell therapy (153)
Clinical research (39877)
Collaboration (316)
Compensation (75)
COVID-19 (1469)
C-suite (82)
Data (1027)
Diabetes (121)
Diagnostics (3408)
Earnings (36164)
Events (50921)
Executive appointments (321)
FDA (12860)
Funding (284)
Gene therapy (90)
GLP-1 (340)
Government (3000)
Healthcare (12156)
Infectious disease (1520)
Inflammatory bowel disease (69)
IPO (7008)
Job creations (1836)
Job search strategy (377)
Layoffs (156)
Legal (3618)
Lung cancer (170)
Lymphoma (66)
Manufacturing (78)
Medical device (12763)
Medtech (12766)
Mergers & acquisitions (10039)
Metabolic disorders (311)
Neuroscience (979)
NextGen: Class of 2025 (3927)
Non-profit (2818)
Northern California (984)
Obesity (175)
Opinion (64)
Parkinson's disease (66)
Patents (70)
People (34345)
Phase I (11426)
Phase II (17271)
Phase III (14171)
Pipeline (346)
Postmarket research (1668)
Preclinical (3545)
Radiopharmaceuticals (158)
Rare diseases (142)
Real estate (2841)
Regulatory (13880)
Research institute (1600)
Southern California (849)
Startups (2120)
United States (9485)
Vaccines (304)
Weight loss (119)
Date
Today (90)
Last 7 days (366)
Last 30 days (1295)
Last 365 days (19652)
2025 (1249)
2024 (19866)
2023 (22755)
2022 (30694)
2021 (32989)
2020 (32196)
2019 (28414)
2018 (21812)
2017 (18907)
2016 (18111)
2015 (21197)
2014 (16026)
2013 (13246)
2012 (14350)
2011 (14626)
2010 (13182)
Location
Africa (353)
Arizona (99)
Asia (24243)
Australia (3837)
California (2206)
Canada (952)
China (253)
Colorado (125)
Connecticut (129)
Delaware (76)
Europe (47274)
Florida (386)
Georgia (93)
Illinois (286)
Indiana (175)
Japan (71)
Kansas (68)
Maryland (506)
Massachusetts (1568)
Michigan (84)
Minnesota (217)
New Jersey (790)
New York (688)
North Carolina (450)
Northern California (984)
Ohio (101)
Pennsylvania (629)
South America (519)
Southern California (849)
Texas (378)
Utah (77)
Washington State (175)
377,143 Results for "istar medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
iSTAR Medical initiates international STAR-VI trial for the use of MINIject in conjunction with cataract surgery
iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announced that the first patients have been implanted in its STAR-VI international trial evaluating the safety and efficacy of MINIject® in conjunction with cataract surgery in patients with primary open-angle glaucoma.
March 15, 2023
·
4 min read
Business
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
AbbVie (NYSE: ABBV) and iSTAR Medical SA, today announced a strategic transaction to further develop and commercialize iSTAR Medical’s MINIject® device, a minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma.
July 20, 2022
·
6 min read
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, presented two-year safety and efficacy results in a meta-analysis of its STAR-I, STAR-II and STAR-III clinical trials for MINIject® at the 15thEuropean Glaucoma Society Congress in Athens.
June 8, 2022
·
5 min read
iSTAR Medical present final results from STAR-II European trial for MINIject in glaucoma patients at AAO
iSTAR Medical today announced final results of the STAR-II European trial for its MIGS device, MINIjectTM.
November 12, 2021
·
6 min read
Policy
iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery, announced that the U.S. Food and Drug Administration granted it Investigational Device Exemption to start a pivotal trial with MINIjectTM.
July 15, 2021
·
3 min read
Press Releases
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
January 9, 2025
·
2 min read
iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial
iSTAR Medical, a medtech company developing minimally invasive ophthalmic implants for treatment of patients with glaucoma, announced positive one-year results from the European STAR-II clinical trial of its micro-invasive glaucoma surgery device, MINIjectTM.
November 16, 2020
·
5 min read
Press Releases
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
October 28, 2024
·
3 min read
News
Tenon Medical(R) Announces Issuance of Three U.S. Patents
October 18, 2024
·
4 min read
Press Releases
AINGENS Launches the Medical Affairs Content Generator (MACg) AI-Powered Medical Writing, Research, and Reference Management Assistant for Life Sciences
January 27, 2025
·
5 min read
1 of 37,715
Next
